Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2844
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 9  |  Issue : 6  |  Page : 2814-2817  

Study to assess the knowledge of caretakers regarding corticosteroid therapy in children with congenital adrenal hyperplasia – 21 hydroxylase deficiency


1 St. John's College of Nursing, SJNAHS, Bangalore, Karnataka, India
2 College of Nursing, Sri Ramachandra Medical College and Research Institution (DU), Porur, Chennai, Tamil Nadu, India
3 Department of Endocrinology, SJMCH, Bangalore, Karnataka, India
4 Department of Paediatrics, Sri Ramachandra Medical College and Research Institution (DU), Porur, Chennai, Tamil Nadu, India

Date of Submission21-Jan-2020
Date of Decision13-Mar-2020
Date of Acceptance31-Mar-2020
Date of Web Publication30-Jun-2020

Correspondence Address:
Dr. Anita David
Sri Ramachandra Medical College and Research Institution (DU), Porur, Chennai - 600 116, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jfmpc.jfmpc_131_20

Rights and Permissions
  Abstract 


Background: The primary aim of treating congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency is to replace the deficient glucocorticoids and mineralocorticoids, to minimize the excess androgen production and to facilitate normal growth. Children with CAH require daily treatment lifelong and increased dosage plan during acute stress, in order to obtain the benefit of optimal outcome from the ongoing treatment schedule. This emphasizes the need for the parents of affected children to be empowered with adequate knowledge regarding such lifesaving therapy. Aims & Objectives: This study was aimed to assess their knowledge regarding corticosteroid therapy. Materials and methods. Caretakers of children with CAH were recruited by using purposive sampling technique. Data was collected by using structured interview technique. Results: It was observed that only 10% of study group had adequate knowledge about therapy and the majority of them were from rural areas, lacking in awareness of essential steps of management. Conclusion: It was concluded that these caretakers need to be given appropriately planned education regarding corticosteroids, drug actions, and the need for enhanced steroid dosage during stress situations. They should also be given relevant instructional materials to read for improving their knowledge about their child's disorder.

Keywords: 21 hydroxylase deficiency, congenital adrenal hyperplasia, parenting, steroid therapy


How to cite this article:
Singarayan V, David A, Ayyar V, James S. Study to assess the knowledge of caretakers regarding corticosteroid therapy in children with congenital adrenal hyperplasia – 21 hydroxylase deficiency. J Family Med Prim Care 2020;9:2814-7

How to cite this URL:
Singarayan V, David A, Ayyar V, James S. Study to assess the knowledge of caretakers regarding corticosteroid therapy in children with congenital adrenal hyperplasia – 21 hydroxylase deficiency. J Family Med Prim Care [serial online] 2020 [cited 2020 Sep 18];9:2814-7. Available from: http://www.jfmpc.com/text.asp?2020/9/6/2814/287830




  Introduction Top


Children with congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency cannot be cured at present, but as long as they receive adequate care and regular treatment, they can lead normal, fulfilling lives. It is an inherited genetic defect in the adrenal cortex which fails to produce corticosteroids and this results in reduced production of glucocorticoids (cortisol) and mineralocorticoids (aldosterone) with a simultaneous excess of adrenal androgens.[1] Cortisol serves a vital physiologic function of maintaining homeostasis and more importantly, helps to combat infections and stressful situations. It is also responsible for maintaining blood sugar levels, which, in turn, is essential to prevent mental confusion and seizures arising from hypoglycaemia. Besides, cortisol is responsible for maintaining normal blood pressure.[2]

For more than six decades now, glucocorticoid therapy has been undoubtedly beneficial as a life-saving drug in the treatment of CAH and thousands of children have survived into adulthood. Treatment of classical CAH is commenced soon after birth and is essential to be continued throughout the patient's life. Daily oral treatment with glucocorticoids (to replace cortisol), mineralocorticoids (to replace aldosterone), and salt supplements are prescribed, particularly in infancy. Throughout the child's life, periodic monitoring of serum hormonal profile is essential as this helps in arriving at the correct treatment dosage for optimal treatment, which, in turn, is crucial to prevent adrenal crisis and virilisation. However, the injudicious use of hydrocortisone may also lead to several undesirable long-term complications, including short stature, precocious puberty, obesity, hypertension, polycystic ovary syndrome, infertility, tumour, osteoporosis, and reduced quality of life. Since during times of high stress or illness, the adrenal glands are normally much more active, to supply more cortisol to help the body meet increased demands and recover rapidly from a life-threatening situation, CAH patients require close monitoring and increased hydrocortisone dosages during illness or after major surgery.

To achieve all the ideals of management, the parents of children with CAH need to be empowered with adequate knowledge regarding the merits of hydrocortisone therapy in this disorder and require support from the team of healthcare providers. Hence, this study was undertaken with the primary objective of assessing the parents' knowledge regarding corticosteroid therapy and the risk of discontinuation of treatment which may result in a highly detrimental 'adrenal crisis' and to plan for an ongoing interventional programme for them. The association between parents' knowledge and baseline variables were also analysed.


  Material and Methods Top


The study was done in the Paediatric Endocrine Outpatient department in a selected hospital in Bengaluru. The research approach adopted for this study was quantitative and descriptive cross-sectional design. Thirty caretakers of children with CAH were recruited by using a purposive sampling technique.[3] Data were collected by using a structured interview schedule. The study was started after obtaining permission from the IEC and IRB authorities. Informed consent was obtained from the caretakers after the study was explained to them. A questionnaire was used to collect data from the caretakers by interview method.

Population

The present study population comprised of all caretakers of children and adolescents between the ages of 1 and 18 years, with CAH 21 hydroxylase deficiency, who could understand English and Kannada and who were willing to participate in the study.

Sample

Samples were selected by using a purposive sampling technique. Thirty caretakers of children who sought treatment for CAH 21 hydroxylase deficiency from the Paediatric Endocrinology OPD of a selected hospital in Bengaluru were chosen for the study.

Criteria for selection

Inclusion criteria: Caretakers of children and adolescents between the ages of 1 and 18 years with CAH 21 hydroxylase deficiency, who could understand English and Kannada and were willing to participate in the study were included.

Exclusion criteria: Caretakers of children with CAH 21 hydroxylase deficiency who were diagnosed for the first time and not yet started on corticosteroid therapy.

Development of the tool

The tool was developed based on a review of the literature and experts' opinions.

Description of the tool

The tool consisted of a structured questionnaire that was divided into two sections.

Section A: Baseline demographic variables containing name, age, and other social information. Section B: Knowledge questionnaire on corticosteroid therapy developed and validated by experts, consisted of eight multiple-choice questions with three options each and four open-ended questions. Each right answer was allotted one mark. The total score was 12.

Data analysis

Data analysis were done by using descriptive and inferential statistical method. The frequency and percentage were calculated to show the distribution of subjects according to baseline variables. The Student's 't' test was used to assess the association between parents' knowledge scores and baseline variables.


  Results Top


Out of the 30 caretakers included in the study, 36.7% were high school educated and 53.3% were mothers and 10% were guardians. The duration of illness in the children was more than 1 year. The majority of parents (63.34%) belonged to the age group of >35 years and 33.33% were between 26 and 35 years; 80% belonged to rural areas. Nearly a third (36.7%) had high school education and 33.4% were graduates [Table 1]. Children studied were equally distributed in the different age groups with no significant differences [Table 2].
Table 1: Description of caretakers according to age and education (n=30)

Click here to view
Table 2: Distribution of children according to the level of education, age, and duration of illness (n=30)

Click here to view


Among the children, 46% were preschoolers and 70% were boys. Concerning knowledge of caretakers, it was observed that 10% had adequate knowledge, 80% had moderate knowledge, and 10% had inadequate knowledge. The mean knowledge score is 7.63 [Table 3]. It was observed that 53% of the caretakers did not know the rationale behind why the drug should be taken after food. Nearly three-fourths (73%) of the caretakers did not know about follow-up.


Click here to view



  Discussion Top


It is widely known that CAH does not have a cure currently but for many decades now, it is well-established worldwide that this disorder can be effectively treated to enable affected children to grow into adulthood and to lead normal fulfilling lives. The treatment in classic CAH begins from birth and is continued throughout life with regular monitoring of clinical and laboratory parameters to help in adequate optimal drug dosing, thereby avoiding side effects. An experienced paediatric team of specialists including endocrinologists, surgeons, clinical geneticists, radiologists, biochemists, psychiatrists, and others is essential for a successful outcome of management. Thus, the need of the parents of affected children to have sound knowledge of their child's condition becomes paramount. While city-dwelling parents with sufficient means of income and education may avail such healthcare amenities with ease, the poorer parents with lesser income and education, hailing from rural areas will remain lacking in essential information regarding effective management and are unable to provide proper care essential to their affected children. Such parents who are often young, are influenced by myths and misconceptions conveyed to them by the elders in the immediate community and are also more vulnerable to suffer from unfounded fears. In general, they are led by lay public to doubt the very efficacy of any long-term drug treatment, however essential it may be.[4] The present study focused on this group of caretakers to assess their knowledge and attitude of CAH in their child and has yielded pilot data to undertake a study in the future to improve their awareness and coping skills.[5]

Nearly two-thirds of the parents are young, hailing from a rural background (80% - [Table 3]C) and not fully educated (~50% – [Table 1]). Knowledge about CAH and its treatment was assessed by using simple, easy-to-understand questions and was found adequate only in 10% of parents studied [Table 3]A. Out of 12 questions to assess the knowledge regarding corticosteroid therapy, 100% responded correctly for the route of administration, but only 16.67% knew correctly as to why the drug should not be stopped suddenly [Table 3]B.[6]

For children with CAH, the provision of life-saving treatment which is highly effective, cost-effective, and not exorbitantly expensive should be within the purview of primary health care, as these children can lead normal lives, by receiving the suitable treatment. With this experience, a larger study is planned to devise a comprehensive interventional study for parents of children with CAH.[7] All aspects of the disorder, including awareness of the condition, the basis of regular compliance with no interruptions in treatment, the importance of stress dosing, and the advantages of regular follow-up will need to be emphasised in a future study.


  Conclusion Top


The study shows that only 10% of parents of children with CAH had adequate knowledge for managing their children effectively. Hence, there is an urgent need to provide essential information to these parents, in the form of group sessions, relevant printed instructional material for reading, and organisation of refresher meetings from time to time for achieving the desired goal of normal growth and good quality of life among children and adolescents with CAH.


  Key Message Top


Parents of children with CAH require to be aware of many details regarding the disorder, the treatment involved for lifelong therapy, stress dosing to overcome life-threatening situations, the regularity of monitoring and followup. Greater effort is urgently needed to improve their knowledge regarding CAH to ensure optimal management and outcome.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms signed by caretakers of children with CAH. In the form, the caretaker(s) has/have given his/her/their consent for clinical information to be reported in the journal. The caretakers understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014; 83:2152-67.  Back to cited text no. 1
    
2.
Hsu CY, Rivkees SA. Congenital adrenal hyperplasia: A parents' guide. Author House. Bloomington, Indiana. 2005.  Back to cited text no. 2
    
3.
Simpson A, Ross R, Porter J, Dixon S, Whitaker MJ, Hunter A. Adrenal Insufficiency in Young Children: a Mixed Methods Study of Parents' Experiences. J Genet Couns 2018;27, 1447–1458.   Back to cited text no. 3
    
4.
Bhakhri BK, Jain V. Congenital adrenal hyperplasia: as viewed by parents of affected children in India – a pilot study. J Pediatr Endocr Met 2011; 24: 959–963.  Back to cited text no. 4
    
5.
de Silva K.S.H, de Zoysa P, Dilanka W.M.S, Dissanayake B.S. Psychological impact on parents of children with congenital adrenal hyperplasia: a study from Sri Lanka. J Pediatr Endocr Met 2014;27:475-8.  Back to cited text no. 5
    
6.
Joshi P, Yadav B, Jain V, Sharma S. Knowledge, stress and adopted coping strategies of parents of children having congenital adrenal hyperplasia: An exploratory survey. Indian Journal of Child Health. 2017; 4:127-32.  Back to cited text no. 6
    
7.
Vidmar AP, Weber JF, Monzavi R, Koppin CM, Kim MS. Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention. J Pediatr Endocrinol Metab 2018;31:213-219.  Back to cited text no. 7
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3]



 

Top
   
 
  Search
 
Similar in PUBMED
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
   Abstract
  Introduction
  Material and Methods
  Results
  Discussion
  Conclusion
  Key Message
   References
   Article Tables

 Article Access Statistics
    Viewed152    
    Printed5    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal